» Articles » PMID: 35743970

Factors Associated with Prolonged RT-PCR SARS-CoV-2 Positive Testing in Patients with Mild and Moderate Forms of COVID-19: A Retrospective Study

Abstract

This article aims to evaluate the number of days necessary for patients with mild and moderate forms of COVID-19 to reach undetectable levels of SARS-CoV-2 RNA in the upper respiratory tract specimens. As a secondary objective, we sought to establish a correlation between different conditions associated with longer viral load as this could result in a longer period of contagion and infectivity. It is a retrospective study. A total of 70 patients with confirmed mild and moderate forms of COVID-19 were enrolled in our study. Number of days with traceable viral load was 25.93 (±6.02) days in patients with mild COVID-19 and 26.97 (±8.30) in moderate form ( = 0.72). Age, male gender, and obesity, along with several chronic conditions (cardiac, liver, renal, and neurological disease), were associated with prolonged positive RT-PCR test from the nasal swab (therefore prolonged viral load). These are in general, risk factors for severe forms of COVID-19. There are several conditions associated with prolonged positive RT-PCR in mild and moderate forms of COVID-19. As to why and what is the significance of it remains to be studied.

Citing Articles

Gut microbiome and clinical and lifestyle host factors associated with recurrent positive RT-PCR for SARS-CoV-2.

Jimenez-Arroyo C, Molinero N, Sabater C, Margolles A, Terron-Camero L, Andres-Leon E Front Cell Infect Microbiol. 2025; 14:1494193.

PMID: 39744158 PMC: 11688222. DOI: 10.3389/fcimb.2024.1494193.


Persistent COVID-19 Infection in an Immunocompromised Host: A Case Report.

Das R, Karyakarte R, Joshi S, Joy M, Sadre A Cureus. 2024; 16(9):e68679.

PMID: 39371780 PMC: 11452762. DOI: 10.7759/cureus.68679.


Factors Associated with Prolonged SARS-CoV-2 Viral Positivity in an Italian Cohort of Hospitalized Patients.

De Grazia S, Pollicino F, Giannettino C, Errera C, Veronese N, Giammanco G Diseases. 2024; 12(7).

PMID: 39057109 PMC: 11275323. DOI: 10.3390/diseases12070138.


COVID-19 and Laboratory Markers from Romanian Patients-A Narrative Review.

Musat O, Sorop V, Sorop M, Lazar V, Marti D, Susan M Life (Basel). 2023; 13(9).

PMID: 37763241 PMC: 10532991. DOI: 10.3390/life13091837.


Assessment of the Function of Respiratory Muscles in Patients after COVID-19 Infection and Respiratory Rehabilitation.

Romaszko-Wojtowicz A, Szalecki M, Olech K, Doboszynska A Trop Med Infect Dis. 2023; 8(1).

PMID: 36668964 PMC: 9860746. DOI: 10.3390/tropicalmed8010057.

References
1.
. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States. Nat Med. 2020; 26(6):861-868. DOI: 10.1038/s41591-020-0877-5. View

2.
Carmo A, Pereira-Vaz J, Mota V, Mendes A, Morais C, da Silva A . Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J Med Virol. 2020; 92(10):2227-2231. PMC: 7301002. DOI: 10.1002/jmv.26103. View

3.
Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View

4.
Mihaltan F, Rajnoveanu A, Rajnoveanu R . Impact of Smoking on Women During the Covid-19 Pandemic. Front Med (Lausanne). 2021; 8:584061. PMC: 8119742. DOI: 10.3389/fmed.2021.584061. View

5.
Long H, Zhao J, Zeng H, Lu Q, Fang L, Wang Q . Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study. BMC Infect Dis. 2021; 21(1):1282. PMC: 8711078. DOI: 10.1186/s12879-021-07002-w. View